US equities |
INTC $65.50 ▼-28.86% AMZN $238.07 ▼-2.35% MU $900.40 ▼-3.63% NVDA $207.73 ▼-2.78% SNDK $1,222.89 ▼-8.06% GOOGL $281.27 ▼-0.90% AMD $515.99 ▼-8.90% TSLA $397.01 ▼-1.56%
FinancialContent

Articles published by Disc Medicine Inc

< Previous 1 2 3 Next >
News headline image
Disc Medicine Announces Pricing of $450 Million Upsized Public Offering of Common Stock
From Disc Medicine Inc
Via GlobeNewswire
Tickers IRON
News headline image
Disc Medicine Announces Proposed $350 Million Public Offering of Common Stock and Pre-Funded Warrants
From Disc Medicine Inc
Via GlobeNewswire
Tickers IRON
News headline image
Disc Medicine Announces Success on All Primary and Secondary Endpoints in the Pivotal Phase 3 APOLLO Trial of Bitopertin in Adults and Adolescents with Erythropoietic Protoporphyria (EPP)
From Disc Medicine Inc
Via GlobeNewswire
Tickers IRON
News headline image
Disc Medicine to Host Corporate Webcast to Discuss Topline Results from the APOLLO Phase 3 Trial of Bitopertin in Erythropoietic Protoporphyria (EPP)
From Disc Medicine Inc
Via GlobeNewswire
Tickers IRON
News headline image
Disc Medicine Presents Initial Results from RESTORE-PV Phase 2 Trial in Patients with Polycythemia Vera (PV) at the 14th Society of Hematologic Oncology (SOHO) Annual Meeting
From Disc Medicine Inc
Via GlobeNewswire
Tickers IRON
News headline image
Disc Medicine to Participate in Upcoming Investor Conferences
From Disc Medicine Inc
Via GlobeNewswire
Tickers IRON
News headline image
Disc Medicine Announces Multiple Presentations Across Portfolio at the Society of Hematologic Oncology (SOHO) 2026 Annual Meeting
From Disc Medicine Inc
Via GlobeNewswire
Tickers IRON
News headline image
Disc Medicine Reports Second Quarter 2026 Financial Results and Provides Business Update
From Disc Medicine Inc
Via GlobeNewswire
Tickers IRON
News headline image
Disc Medicine Presents Positive Clinical Updates at the 2026 European Hematology Association (EHA) Annual Meeting
From Disc Medicine Inc
Via GlobeNewswire
Tickers IRON
News headline image
Disc Medicine Provides Update from FDA Type A Meeting for Bitopertin in Erythropoietic Protoporphyria
From Disc Medicine Inc
Via GlobeNewswire
Tickers IRON
News headline image
Disc Medicine Presents Updated Positive Data from RALLY-MF Phase 2 Trial in Patients with Myelofibrosis (MF) and Anemia at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting
From Disc Medicine Inc
Via GlobeNewswire
Tickers IRON
News headline image
Disc Medicine Launches Expanded Access Program for Bitopertin for EPP Patients
From Disc Medicine Inc
Via GlobeNewswire
Tickers IRON
News headline image
Disc Medicine Announces Multiple Presentations Across Portfolio at the European Hematology Association (EHA) 2026 Congress
From Disc Medicine Inc
Via GlobeNewswire
Tickers IRON
News headline image
Disc Medicine to Participate in Upcoming Investor Conferences
From Disc Medicine Inc
Via GlobeNewswire
Tickers IRON
News headline image
Disc Medicine Reports First Quarter 2026 Financial Results and Provides Business Update
From Disc Medicine Inc
Via GlobeNewswire
Tickers IRON
News headline image
Disc Medicine Announces Oral Presentation of Data from RALLY-MF Phase 2 Trial of DISC-0974 in Patients with Myelofibrosis and Anemia at the American Society of Clinical Oncology (ASCO) Annual Meeting
From Disc Medicine Inc
Via GlobeNewswire
Tickers IRON
News headline image
Disc Medicine Announces Completion of Enrollment of Phase 3 APOLLO Trial of Bitopertin in Erythropoietic Protoporphyria
From Disc Medicine Inc
Via GlobeNewswire
Tickers IRON
News headline image
Disc Medicine Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
From Disc Medicine Inc
Via GlobeNewswire
Tickers IRON
News headline image
Disc Medicine to Participate in Upcoming Investor Conferences
From Disc Medicine Inc
Via GlobeNewswire
Tickers IRON
News headline image
Disc Medicine Receives Complete Response Letter from FDA for Bitopertin for the Treatment of EPP
From Disc Medicine Inc
Via GlobeNewswire
Tickers IRON
News headline image
Disc Medicine Appoints Lisa Amaya Price, MBA as Chief Human Resources Officer
From Disc Medicine Inc
Via GlobeNewswire
Tickers IRON
News headline image
Disc Medicine Highlights Recent Achievements and Key Business Objectives and Milestones for 2026
From Disc Medicine Inc
Via GlobeNewswire
Tickers IRON
News headline image
Disc Medicine to Present at the 44th Annual J.P. Morgan Healthcare Conference
From Disc Medicine Inc
Via GlobeNewswire
Tickers IRON
News headline image
Disc Medicine Presents Positive Initial Data from RALLY-MF Phase 2 Trial in Patients with Myelofibrosis (MF) and Anemia at the 67th American Society of Hematology (ASH) Annual Meeting
From Disc Medicine Inc
Via GlobeNewswire
Tickers IRON
News headline image
Disc Medicine Reports Third Quarter 2025 Financial Results and Provides Business Update
From Disc Medicine Inc
Via GlobeNewswire
Tickers IRON
News headline image
Disc Medicine Announces Presentation of Initial Data from RALLY-MF Phase 2 Trial in Patients with Myelofibrosis (MF) and Anemia at the 67th American Society of Hematology (ASH) Annual Meeting
From Disc Medicine Inc
Via GlobeNewswire
Tickers IRON
News headline image
Disc Medicine to Participate in Upcoming Investor Conferences
From Disc Medicine Inc
Via GlobeNewswire
Tickers IRON
News headline image
Disc Medicine Announces Pricing of $250 Million Upsized Public Offering of Common Stock and Pre-Funded Warrants
From Disc Medicine Inc
Via GlobeNewswire
Tickers IRON
News headline image
Disc Medicine Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
From Disc Medicine Inc
Via GlobeNewswire
Tickers IRON
News headline image
Disc Medicine Provides Update on Hematology Portfolio and Outlines Near-Term Business Objectives and Anticipated Milestones
From Disc Medicine Inc
Via GlobeNewswire
Tickers IRON
< Previous 1 2 3 Next >